|
|
|
Volumn 104, Issue 4 Pt 1, 1999, Pages
|
|
IMpact-RSV Study Group report.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
MONOCLONAL ANTIBODY;
PALIVIZUMAB;
HUMAN;
INFANT;
INTRAMUSCULAR DRUG ADMINISTRATION;
NOTE;
PAIN;
VIRUS INFECTION;
COST BENEFIT ANALYSIS;
ECONOMICS;
ANTIBODIES, MONOCLONAL;
HUMANS;
INFANT;
INJECTIONS, INTRAMUSCULAR;
PAIN;
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;
COST-BENEFIT ANALYSIS;
|
|
EID: 0033212109
PISSN: 00314005
EISSN: None
Source Type: Journal
DOI: None Document Type: Note |
|
Times cited : (9)
|
|
References (0)
|
